66，Dzau VJ, Mukoyama M, Pratt RE. Molecular biology of angiotensin receptors:target fordrug research. J Hypertens, 1994, 12(Suppl 2):1
77，Burnier M, Waeher B, Brunner HR. The advantages of angiot-ensinⅡ antagonism. JHypertens,1994,12(Suppl 2):7
88，uncia JV, Chiu AT, Carini DJ, et al. The discovery of potent nonpeptide angiotensinⅡ receptor antagonists:a new class of potent antihypertensives. J Med Chem,1990,33:1312
99， Edvinsson L, Erlinge D, Sun XY, et al. Neuropeptide Y in sympathetic co-transmission:recent advances in the search forneuropeptide Y antagonists. Pharmacol Toxicol,1994,74(4/5): 193
1010，Adamsson M, Fallgren B, Edvinsson L. Inhibition of neur opeptide Y-inducedpotentiation of noradrenaline induced vasocons triction by PP56(D-myo-inositol1,2,6-tris-phosphate). Br J Pharmacol,1992,105(1):93
